At 8M market cap with a 2M+ net profit forecast, we are very cheap. The price doesn't include any of the growth potential of UAV and XTclave.
ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025